Brought to you by 
Inverness Medical Innovations buys MedPointe's Wampole Lab
12 Jun 2003
Executive Summary
Inverness Medical Innovations (women's health diagnostics, vitamins, nutritional supplements, and medical device technologies) is acquiring Wampole Laboratories, the immunoassay diagnostic division of pharmaceutical company MedPointe, for $70mm in cash, about 1.75 times its revenue for the 3/02 fiscal year.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inverness Medical Innovations buys MedPointe's Wampole Lab
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice